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See related research by Donati et al., http://ccforum.com/content/18/1/R33Donati and colleagues [1] evaluated the benefits of fresh,
leukodepleted (LD) versus non-leukodepleted (nLD) ery-
throcyte transfusions on the microcirculation in sepsis
patients. Oxygenation appeared equal in both groups.
Differences between the two kinds of blood cells are pre-
sented in Table 1. In the reported study, there is a differ-
ence between the age of erythrocytes in the two groups
(1.5 to 3 days for nLD versus 3.5 to 5 days for LD erythro-
cytes; a U test indicates P < 0.05); this suffices to influence
oxygen delivery mediators (Figure 1). The content of
leukocytes prior to (and after) leukodepletion were
not tested, nor was the freeing - which is usually very
fast - of secreted or docked, soluble biological response
modifiers. Considering the dynamics of secreted biological
response modifiers in platelet components [2], there
must be differences within the two groups, which possibly* Correspondence: ogarraud@ints.fr
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unless otherwise stated.influenced sepsis conditions. Residual plasma within
erythrocytes given by female donors may include anti-
human leukocyte antigen (HLA) antibodies which attack
the recipient’s lung alveolar epithelium neutrophils, and as
sepsis is characterized by the pathology of neutrophils that
release microparticles and neutrophil extracellular traps
that target lung epithelium [3], it may be feared here that
the nLD condition aggravates pulmonary lesions.
The re-evaluation of procedures is infrequent in trans-
fusion despite the rapid evolution of techniques and ma-
terials; for example, differential stresses are inflicted on
erythrocytes, depending on the collection process (aphaer-
esis versus conventional whole blood), with consequences
for neutrophils and (vascular) endothelial cells upon trans-
fusion [4]. Clinical investigations and registered trials such
as Donati and colleagues are valuable.and Can InceWe thank Professor Garraud and colleagues for their
interest in our study [1]. As underlined, the difference in
the age of transfused red blood cells (RBCs) between the
nLD group (4 (3.5 to 5) days) and the LD group (3 (1.5 to
3) days) may have influenced the RBC oxygen-delivery
capacity. Stored RBCs lose their ability to release vasodila-
tors (nitric oxide, ATP) during hypoxia [5,6]. We showed
similar changes in microvascular reactivity (tissue oxygen
saturation (StO2)-upslope) and oxygenation (StO2) after
nLD or LD RBC transfusions [1]. This may indicate that
oxygen-delivery mediators were not sufficiently affected to
determine relevant variations in the response observed.Alternatively, heterogeneity in the study population pre-
vented detection of subtle differences. Variability in
the response to treatments is common during sepsis. The
patient heterogeneity was underlined as a limitation of
our investigation [1].
LD RBCs showed a more favorable effect on microcir-
culatory convective flow [1]. This may depend on the
lower adhesiveness of LD RBCs to the endothelium [7].
The transfusion of nLD RBCs decreased blood flow
velocity and increased glycocalyx damage markers [1].
Similar effects may reasonably occur in the lungs. As
highlighted, anti-HLA antibodies in nLD blood from
female donors may contribute to aggravate pulmonary
lesions. Nonetheless, the evaluation of respiratory func-
tion went beyond our goals.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Possible consequences of variation in transfusion conditions and the type of packed red blood cells administered
Variable Primary or immediate consequences (efficacy) Secondary or delayed consequences (hazards)
Total volume Possibly needs to be adjusted according to the patient's needs Possibly needs to be adjusted to correct for anemia
Hematocrit Possibly needs to be adjusted according to the patient's needs Possibly needs to be adjusted to correct for anemia
Residual plasma volume Possibly includes anti-HLA antibodies (from female donors) Increases the risk of TRALI
Increases the risk of inflammation and aggravates
the risk of TRALI
Possibly affects the amount of soluble, free biological
response modifiers
Leukocytes No pre-test (possibly affects donor eligibility)
Pre-activation of leukocytes Increases the risk of inflammation
Release of biological response modifiers
Release of microparticles and neutrophil extracellular Aggravates sepsis
traps Increases the risk of TRALI
HLA antibody targets Increases the risk of viral infections
Infectious risk (intracellular viruses)
Age of blood Decreases the benefit of oxygen transport
Release of microparticles Increases the risk of inflammation
Expression of stress signals on red blood cells
Free iron release Potentiates the risk of TRALI by stressing target
NO and iNOS release neutrophils
Oxygenated lipid and lipid degradation
Possibly increases the risk of allo-immunization
HLA, human leukocyte antigen; iNOS, inducible nitric oxide synthase; NO, nitric oxide; TRALI, transfusion-related acute lung injury.
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Figure 1 ATP and 2,3-diphosphoglycerate (2.3-DPG) in packed red blood cells. (A) ATP and (B) 2.3-DPG in packed red blood cells measured
after 1, 7, 14, 21, 28, 35 and 42 days (d) of storage were re-evaluated by one-way analysis of variance. Inter-experiment differences in ATP and
2.3-DPG concentrations at different time points were analyzed by Wilcoxon paired test (XLSTAT® 2010 software, Addinsoft, Paris, France).
P-values ≤0.05 were considered to be significant (*n = 10). PLT, platelet.
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tiple RBC- and patient-related factors. Understanding
the response to transfusion during sepsis is a challenging
task. Targeting predetermined hemoglobin levels and/or
macrohemodynamics is clearly not sufficient. Monitoring
the microcirculation may get us closer to the answer [8].
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